Growth Metrics

Solid Biosciences (SLDB) Common Equity (2017 - 2026)

Quarterly results put Common Equity at $374.1 million for Q1 2026, up 27.06% from a year ago — trailing twelve months through Mar 2026 was $374.1 million (up 27.06% YoY), and the annual figure for FY2025 was $180.0 million, up 31.16%.

Solid Biosciences has reported Common Equity over the past 10 years, most recently at $374.1 million for Q1 2026.

  • Common Equity reached $374.1 million in Q1 2026 per SLDB's latest filing, up from $180.0 million in the prior quarter.
  • Across five years, Common Equity topped out at $374.1 million in Q1 2026 and bottomed at $126.5 million in Q4 2023.
  • Median Common Equity over the past 5 years was $183.8 million (2023), compared with a mean of $197.3 million.
  • The largest annual shift saw Common Equity crashed 40.25% in 2023 before it surged 39.74% in 2025.
  • Over 5 years, Common Equity stood at $211.7 million in 2022, then plummeted by 40.25% to $126.5 million in 2023, then increased by 8.51% to $137.2 million in 2024, then surged by 31.16% to $180.0 million in 2025, then surged by 107.84% to $374.1 million in 2026.
  • Business Quant data shows Common Equity for SLDB at $374.1 million in Q1 2026, $180.0 million in Q4 2025, and $217.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -1.42 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 35.63 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 1.00 Bn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 19.36 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 31.42 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - 13.21 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 1.08 Bn
10 Solid Biosciences 713.77 Mn 333.09 Mn - 374.13 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 374.13 Mn
Dec 31, 2025 180.01 Mn
Sep 30, 2025 217.95 Mn
Jun 30, 2025 258.29 Mn
Mar 31, 2025 294.46 Mn
Dec 31, 2024 137.25 Mn
Sep 30, 2024 167.02 Mn
Jun 30, 2024 193.25 Mn
Mar 31, 2024 210.72 Mn
Dec 31, 2023 126.48 Mn
Sep 30, 2023 144.36 Mn
Jun 30, 2023 163.73 Mn
Mar 31, 2023 183.79 Mn
Dec 31, 2022 211.67 Mn
Sep 30, 2022 143.28 Mn
Jun 30, 2022 162.24 Mn
Mar 31, 2022 185.51 Mn
Dec 31, 2021 208.21 Mn
Sep 30, 2021 223.36 Mn
Jun 30, 2021 237.94 Mn
Mar 31, 2021 253.00 Mn
Dec 31, 2020 132.09 Mn
Sep 30, 2020 22.23 Mn
Jun 30, 2020 40.71 Mn
Mar 31, 2020 56.46 Mn
Dec 31, 2019 80.05 Mn
Sep 30, 2019 108.53 Mn
Jun 30, 2019 76.50 Mn
Mar 31, 2019 99.11 Mn
Dec 31, 2018 125.18 Mn
Sep 30, 2018 145.07 Mn
Jun 30, 2018 162.29 Mn
Mar 31, 2018 178.95 Mn
Dec 31, 2017 -59.26 Mn